Literature DB >> 20501997

The Canadian Neurological Scale and the NIHSS: development and validation of a simple conversion model.

Yongchai Nilanont1, Chulaluk Komoltri, Gustavo Saposnik, Robert Côté, Silvia Di Legge, Yaping Jin, Naraporn Prayoonwiwat, Niphon Poungvarin, Vladimir Hachinski.   

Abstract

BACKGROUND: The Canadian Neurological Scale (CNS) and the National Institutes of Health Stroke Scale (NIHSS) are among the most reliable stroke severity assessment scales. The CNS requires less extensive neurological evaluation and is quicker and simpler to administer.
OBJECTIVE: Our aim was to develop and validate a simple conversion model from the CNS to the NIHSS.
METHODS: A conversion model was developed using data from a consecutive series of acute-stroke patients who were scored using both scales. The model was then validated in an external dataset in which all patients were prospectively assessed for stroke severity using both scales by different observers which consisted of neurology residents or stroke fellows.
RESULTS: In all, 168 patients were included in the model development, with a median age of 73 years (20-94). Men constituted 51.8%. The median NIHSS score was 6 (0-31). The median CNS score was 8.5 (1.5-11.5). The relationship between CNS and NIHSS could be expressed as the formula: NIHSS = 23 - 2 x CNS. A cohort of 350 acute-stroke patients with similar characteristics was used for model validation. There was a highly significant positive correlation between the observed and predicted NIHSS score (r = 0.87, p < 0.001). The predicted NIHSS score was on average 0.61 higher than the observed NIHSS score (95% CI = 0.31-0.91).
CONCLUSIONS: The CNS can be reliably converted to the NIHSS using a simple conversion formula: NIHSS = 23 - 2 x CNS. This finding may have a practical impact by permitting reliable comparisons with NIHSS-based evaluations and simplifying the routine assessment of acute-stroke patients in more diverse settings. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20501997     DOI: 10.1159/000314715

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  7 in total

1.  Predictors of diagnostic neuroimaging delays among adults presenting with symptoms suggestive of acute stroke in Ontario: a prospective cohort study.

Authors:  Kirsteen R Burton; Moira K Kapral; Shudong Li; Jiming Fang; Alan R Moody; Murray Krahn; Andreas Laupacis
Journal:  CMAJ Open       Date:  2016-06-20

2.  THRIVE score predicts outcomes with a third-generation endovascular stroke treatment device in the TREVO-2 trial.

Authors:  Alexander C Flint; Bin Xiang; Rishi Gupta; Raul G Nogueira; Helmi L Lutsep; Tudor G Jovin; Gregory W Albers; David S Liebeskind; Nerses Sanossian; Wade S Smith
Journal:  Stroke       Date:  2013-09-26       Impact factor: 7.914

3.  Red cell distribution width and neurological scoring systems in acute stroke patients.

Authors:  Hasan Kara; Selim Degirmenci; Aysegul Bayir; Ahmet Ak; Murat Akinci; Ali Dogru; Fikret Akyurek; Seyit Ali Kayis
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-18       Impact factor: 2.570

Review 4.  Prediction of Walking and Arm Recovery after Stroke: A Critical Review.

Authors:  Li Khim Kwah; Robert D Herbert
Journal:  Brain Sci       Date:  2016-11-02

5.  2D:4D Ratio Differs in Ischemic Stroke: A Single Center Experience.

Authors:  Ke Yang; XianHui Ding; ZhiMing Zhou; XiaoLei Shi
Journal:  Transl Neurosci       Date:  2018-11-12       Impact factor: 1.757

6.  Predicting mortality in acute ischaemic stroke treated with mechanical thrombectomy: analysis of a multicentre prospective registry.

Authors:  Hao Li; Shi-Sheng Ye; Yuan-Ling Wu; Sheng-Ming Huang; Yong-Xin Li; Kui Lu; Jing-Bo Huang; Lve Chen; Hong-Zhuang Li; Wen-Jun Wu; Zhi-Lin Wu; Jian-Zhou Wu; Wang-Tao Zhong; Wen-Chuan Xian; Feng Liao; Tao-Hsin Tung; Qiao-Ling Wu; Hai Chen; Li Yuan; Zhi Yang; Li-An Huang
Journal:  BMJ Open       Date:  2021-04-01       Impact factor: 2.692

Review 7.  Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials.

Authors:  Stefan Strilciuc; László Vécsei; Dana Boering; Aleš Pražnikar; Oliver Kaut; Peter Riederer; Leontino Battistin
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.